Valuation: Consort Medical plc

Market Cap 502M 434M 405M 372M 700M 47.77B 711M 4.76B 1.87B 23.94B 1.88B 1.84B 79.15B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 518M 484M 444M 835M 57.04B 849M 5.68B 2.23B 28.59B 2.25B 2.2B 94.51B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 52 2024-03-31
Director/Board Member 46 2023-01-31
Director/Board Member 53 2024-03-31
Date Insider Type Main position Quantity % Market Cap.
2/6/20 Sell 211,474 0.4284%
2/6/20 Fiscal year 211,474 0.4284%
2/6/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
-0.14%+2.00%-19.71%+2.38% 187B
+1.44%+2.07%-6.16%+5.09% 112B
-1.40%+2.93%+12.39%+72.56% 61.15B
+2.38%+3.92%+32.78%+60.21% 54.39B
-0.12%+6.79%-8.60%-37.18% 48.17B
+2.08%+1.56%+7.47%-23.62% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+46.93%-11.52% 24.92B
+2.45%+3.97%-2.22%+4.63% 23.15B
Average +1.04%+1.73%+7.86%+9.07% 57.34B
Weighted average by Cap. +0.70%+2.17%-1.63%+11.07%

Financials

2018 2019
Net sales 311M 269M 251M 231M 434M 29.61B 440M 2.95B 1.16B 14.84B 1.17B 1.14B 49.06B 305M 264M 246M 226M 425M 29.04B 432M 2.89B 1.13B 14.55B 1.15B 1.12B 48.11B
Net income 16.1M 13.93M 13.01M 11.93M 22.44M 1.53B 22.8M 153M 59.89M 768M 60.46M 59.14M 2.54B 10.5M 9.08M 8.48M 7.78M 14.63M 999M 14.87M 99.51M 39.06M 501M 39.43M 38.57M 1.66B
Net Debt 95.5M 82.61M 77.14M 70.77M 133M 9.09B 135M 905M 355M 4.56B 359M 351M 15.06B 97.4M 84.25M 78.68M 72.18M 136M 9.27B 138M 923M 362M 4.65B 366M 358M 15.36B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock